英文名稱 |
中文名稱 |
CAS號 |
操作 |
NA |
Azilsartan Impurity 23 (美阿沙坦開環(huán)雜質 U-4) |
|
詳細
|
METHYL2-(CHLOROMETHYL)PHENYL)PROPIONATE(MIXTURE) |
洛索洛芬鈉雜質P3-1對照品 |
80530-54-7 |
詳細
|
2-(4-chloromethyl-phenyl)-propionic acid ethyl ester |
洛索洛芬鈉雜質P4-1對照品 |
43153-03-3 |
詳細
|
2-[(4-Acetylphenyl)methyl]cyclopentan-1-one |
洛索洛芬雜質G |
96824-28-1 |
詳細
|
4β-Hydroxy Cholesterol-d4 (Major) |
4β-羥基膽固醇-[d4] |
1363529-44-5 |
詳細
|
Decarboxy Moxifloxacin 2 |
3-脫羧莫西沙星 |
929102-25-0 |
詳細
|
ALOIN |
蘆薈素 |
8015-61-0 |
詳細
|
N-[[(5R)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide |
利奈唑胺雜質R |
872992-20-6 |
詳細
|
1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide |
硫酸特布他林雜質D |
94109-61-2 |
詳細
|
3-Oxo-2-quinuclidinecarboxylic acid ethyl ester |
鹽酸戊乙奎醚雜質SM2-C |
34286-16-3 |
詳細
|
(S)-Phenylephrine hydrochloride |
對映異構體 |
939-38-8 |
詳細
|
2-Anthracenecarboxaldehyde, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo- |
大黃醛 |
154658-30-7 |
詳細
|
3-[2-(methylamino)ethyl]phenol hydrobromide |
鹽酸去氧腎上腺素雜質G |
61186-06-9 |
詳細
|
8-Chloro-11-fluoro-6,11-dihydro-11-(4-piperidinyl)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
氟地氯雷他定 |
298220-99-2 |
詳細
|
1-NaphthaleneMethanaMine, 5,6,7,8-tetrahydro-α-Methyl-, (αR)- |
鹽酸西那卡塞XNKS-B-3 |
851984-49-1 |
詳細
|
Cinacalcet Impurity D |
鹽酸西那卡塞雜質F |
1271930-15-4 |
詳細
|
Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl- |
布南色林INT2-D |
132813-13-9 |
詳細
|
Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-(4-methoxyphenyl)- |
布南色林INT2-I(雜質19) |
132813-20-8 |
詳細
|
5-[(4-amino-2-carboxyphenyl)amino]-2-hydroxybenzoic acid |
美沙拉秦EP雜質S(2-羥基-5-[(2-羧基-4-氨基苯基)氨基]苯甲酸) |
1797983-23-3 |
詳細
|
N-deacetyllappaconitine |
N-去乙酰高烏甲素 |
11033-64-0 |
詳細
|
NA |
西地那非亞硝基雜質 |
|
詳細
|
2,3-Difluoro-4-nitroaniline |
2,3-二氟-4-硝基苯胺 |
1781140-23-5 |
詳細
|
cefixime |
頭孢克肟EP雜質C |
108691-83-4 |
詳細
|
2-Oxazolemethanol, 2,5-dihydro-α,2,4,5-tetramethyl- |
1-(2,4,5-三甲基-2,5-二氫噁唑-2-基)-乙醇 |
171202-48-5 |
詳細
|
L-Cefadroxil |
頭孢羥氨芐EP雜質D |
144790-28-3 |
詳細
|
Pyrazine, tetramethyl-, 1-oxide (8CI,9CI) |
2,3,5,6-四甲基吡嗪-1-氧 |
22978-83-2 |
詳細
|
3,4-Dichloro-7-methylquinoline-6-carboxamide |
3,4-二氯-7-甲基喹啉 -6-甲酰胺 |
|
詳細
|
Isaconazole sulfate impurity BAL30078 |
硫酸艾沙康唑雜質BAL30078 |
|
詳細
|
Afatinib maleate impurity I-G |
馬來酸阿法替尼雜質I-G |
2983348-69-0 |
詳細
|
8-((3R,4S)-4-ethylpyrrolidine-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide |
8-((3R, 4S)-4-乙基吡咯烷-3-基)-N-(2,2,2-三氟乙基)-3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪-3-甲酰胺 |
|
詳細
|
Dimeric 7-ACA |
7-ACA二聚體 |
|
詳細
|
BGLT-18-Pioglitazone Impurity PGR-II. |
BGLT-18-吡格列酮雜質PGR-Ⅱ |
|
詳細
|
(3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate |
(3R,4R)-3-(2-溴乙?;?4-乙基吡咯烷-1-甲酸芐酯 |
|
詳細
|
BGLT-20-Pioglitazone Impurity PIO-II. |
BGLT-20-吡格列酮雜質PIO-Ⅱ |
|
詳細
|
DL-Threitol |
DL-蘇糖醇 |
7493-90-5 |
詳細
|
Afatinib Impurity des-EJA |
阿法替尼雜質DES-EJA |
2223677-64-1 |
詳細
|
2-[3-[4-(3,4-dichlorophenyl)piperazine-1-yl]propyl][1,2,4]triazol[4,3-a]pyridine-3(2H)-one |
2-[3-[4-(3,4-二氯苯基)哌嗪-1-基]丙基][1,2,4]三唑并[4,3-a]吡啶-3(2H)-酮 |
|
詳細
|
Posaconazole Impurity 35 (Oxalate) |
泊沙康唑雜質35(草酸鹽) |
|
詳細
|
Ipratropium Bromide Impurity K |
異丙托溴銨EP雜質K |
17838-69-6 |
詳細
|
Clindamycin eighteen carbonate salt control |
克林霉素十八碳酸酯鹽對照品 |
1123211-70-0 |
詳細
|
DEFLAZACORT |
地那查可特 |
13649-88-2 |
詳細
|
Mirogabalin besylateSM1- impurity A |
苯磺酸美洛加巴林/SM1-雜質A |
344428-05-3 |
詳細
|
Metoclopramide EP impurity H |
甲氧氯普胺EP雜質H |
50-86-2 |
詳細
|
N-YXIPD |
艾氟康唑雜質81 (N-亞硝基艾氟康唑雜質36 單體) |
3053220-60-0 |
詳細
|
Eplerenone EP Impurity D |
依普利酮EP雜質D |
209253-82-7 |
詳細
|
Paliperidone Impurity J |
帕潘立酮雜質J |
1138463-56-5 |
詳細
|
Axitinib Acid |
阿昔替尼酸 |
319462-34-5 |
詳細
|
Clindamycin EP Impurity C |
克林霉素EP雜質C |
16684-06-3 |
詳細
|
Axitinib Sulfoxide |
阿昔替尼砜 |
1348536-59-3 |
詳細
|
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-N-cyclopropyl-7-methoxy-6-quinoline carboxamide |
4-[3-氯-4-[[(環(huán)丙基氨基)羰基]氨基]苯氧基]-N-環(huán)丙基-7-甲氧基-6-喹啉甲酰胺 |
417717-22-7 |
詳細
|
Ibuprofen-d3 |
氘代布洛芬 |
121662-14-4 |
詳細
|
1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl][1,2,4]triazolo[4,3-a]pyridine-1-ium-3-ol/trazodone hydrochloride USP Impurity M |
1-[3-[4-(3-氯苯基)哌嗪-1-基]丙基][1,2,4]三唑并[4,3-a]吡啶-1-鎓-3-醇/鹽酸曲唑酮USP 雜質 M |
157072-18-9 |
詳細
|
Rivaroxaban associated impurity 1 |
利伐沙班相關雜質 1 |
31166-29-7 |
詳細
|
chlorosulfanylthiohypochlorite,4-(2-methylbutan-2-yl)phenol |
4-(1,1-二甲基內基)苯酚與二氯化二碗的聚合物 |
68555-98-6 |
詳細
|
3-Amino-2-chlorophenol |
3-氨基-2-氯苯酚 |
56962-01-7 |
詳細
|
O-toluenesulfonic acid (2-methylbenzenesulfonic acid) |
鄰甲苯磺酸(2-甲基苯磺酸) |
88-20-0 |
詳細
|
Metoclopramide EP impurity A |
甲氧氯普胺EP雜質A |
5608-13-9 |
詳細
|
1-((dimethylamino)methyl)-7-phenoxyisoquinolin-4-ol |
1-甲基-4-羥基-7-苯氧基異喹啉 |
2756726-89-1 |
詳細
|
3-[4-(3-chlorophenyl)piperazin-1-yl]propan-1-ol |
3-[4-(3-氯苯基)哌嗪-1基]丙-1-醇 |
32229-98-4 |
詳細
|
Lincomycin Impurity B |
林可霉素B對照品 |
2520-24-3 |
詳細
|
Metoclopramide EP impurity B |
甲氧氯普胺EP雜質B |
4093-31-6 |
詳細
|
Leucoson |
利可君 |
1950-36-3 |
詳細
|
Posaconazole Enantiomer |
泊沙康唑非對應異構體 |
2243785-97-7 |
詳細
|
BM2-d |
2,4-二硝基苯基苯基醚 |
002486-07-9 |
詳細
|
4-Methoxy-1,2-phenylenediamine(SM1-1) |
4-甲氧基-1,2-苯二胺(SM1-1) |
102-51-2 |
詳細
|
2-Methoxy-5-nitroaniline(SM1-7) |
2-甲氧基-5-硝經基苯(SM1-7) |
99-59-2 |
詳細
|
BM1-d |
2,4-二硝基氯苯 |
97-00-7 |
詳細
|
2,3,5-trimethyl-4-nitro-1-oxidopyridin-1-ium(SM2-2) |
2,3,5-三甲基-4-硝基吡啶氮氧化物(SM2-2) |
86604-79-7 |
詳細
|
N-hydroxyaniline control |
N-羥基苯胺對照品 |
100-65-2 |
詳細
|
2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-piperidine-N-oxo-1-yl}-ethyl)-phenyl]-2-methylpropionic acid |
2-[4-(2-{4-[1-(2-乙氧基乙基)-1H-苯并咪唑-2-基]-哌啶-N-氧-1-基}-乙基)-苯基]-2-甲基丙酸 |
2069238-47-5 |
詳細
|
2-(4-(2-hydroxyethyl)phenyl)-2-Methylpropanoic acid |
2-(4-(2-羥乙基)苯基)-2-甲基丙酸 |
552301-45-8 |
詳細
|
2-[1-(4-BROMOPHENYL)-1-METHYLETHYL]-4,4-DIMETHYL-4,5-DIHYDROOXAZOLINE |
2-[1-(4-溴苯基)-1-甲基乙基]-4,5-二氫-4,4-二甲基惡唑 |
192775-97-6 |
詳細
|
tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate |
1-哌啶甲酸-4-[1-(2-乙氧基乙基)-1H-苯并咪唑-2-基]-1,1-二甲基乙酯 |
1181267-36-6 |
詳細
|
Oseltamivir Impurity1 |
奧司他韋雜質1 |
3044729-56-5 |
詳細
|
2-[4-(2-[4-(1H-benzimidazol-2-yl])piperidin-1-yl]ethyl)phenyl]-2-methylpropionic acid |
2-[4-(2-[4-(1H-苯并咪唑-2-基])哌啶-1-基]乙基)苯基]-2-甲基丙酸 |
2099128-83-1 |
詳細
|
methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate |
alpha,alpha-二甲基-4-[2-[[(4-甲基苯基)磺?;鵠氧基]乙基]苯乙酸甲酯 |
1181267-30-0 |
詳細
|
4-[1-(2-methoxy-ethyl)-1H-benzimidazole-2-yl]-piperidin-1-carboxylic acid tert-butyl ester |
4-[1-(2-甲氧基-乙基)-1H-苯并咪唑-2-基]-哌啶-1-甲酸叔丁酯 |
1815602-35-7 |
詳細
|
4-methoxy-2,3,5-trimethylpyridine 1-oxide(SM2-3 ) |
2,3,5-三甲基-4-甲氧基吡啶氮氧化物(SM2-3 ) |
86604-80-0 |
詳細
|
Oseltamivir Impurity2 |
奧司他韋雜質2 |
94154-89-9 |
詳細
|
Methyl 2-(4-(2-hydroxyethyl)phenyl)-2-methylpropionate |
甲基2-(4-(2-羥基乙基)苯基)-2-甲基丙酸甲酯 |
1000536-33-3 |
詳細
|
Ethyl 2-[(methoxycarbonylethyl)(toluene-4-sulfonyl)amino]methyl-4-phenoxybenzoate |
2-[(甲氧基羰基乙基)(甲苯-4-磺酰)氨基]甲基-4-苯氧基苯甲酸乙酯 |
|
詳細
|
Ethyl 2-(chloromethyl)-4-phenoxybenzoate |
2-(氯甲基)-4-苯氧基苯甲酸乙酯 |
|
詳細
|
2-Oxo-1,2-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester |
2-氧-1,2-二氫-[1,8]萘啶-3-甲酸乙酯 |
5174-90-3 |
詳細
|
N-(2-PyridylMethyl)glycine Ethyl Ester |
N-(2-吡啶甲基)甘氨酸乙酯 |
62402-24-8 |
詳細
|
N-nitroso-timolol |
N-亞硝基噻嗎洛爾 |
|
詳細
|
Thioctic Acid Impurity H |
硫辛酸雜質H |
188783-96-2 |
詳細
|
2,4-Diaminoanisole |
2,4-二氨基苯甲醚(SM1-8) |
615-05-4 |
詳細
|
Phenylmethyl(3S,4S)-3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-B]pyrazine-2-yl]amino]acetyl]-4 ethyl 1-pyrrolidincarboxylate |
苯甲基(3S,4S)-3-[2-[(乙氧基羰基)[5-[(4-甲基苯基)磺酰基]-5H-吡咯并[2,3-B]吡嗪-2-基]氨基]乙?;鵠-4 1-吡咯烷甲酸乙酯 |
2715120-95-7 |
詳細
|
4-Chloro-2-(propylthio)pyrimidine-5-amine (MDIP-15) |
4-氯-2-(丙基硫代)嘧啶-5-胺(MDIP-15) |
2518048-22-9 |
詳細
|
869 Impurity M |
869雜質M |
185336-12-3 |
詳細
|
N-Nitroso Anatabine |
N-亞硝基新煙堿 |
887407-16-1 |
詳細
|
N-Nitrosoanabasine |
N-亞硝基假木賊堿 |
1133-64-8 |
詳細
|
4-(3-chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide |
4-(3-氯-4-脲基-苯氧基)-7-甲氧基-喹啉-6-羧酸酰胺 |
417719-51-8 |
詳細
|
2-Nitropropane-1,3-Diol |
2-硝基-1,3-丙二醇鈉鹽 |
1794-90-7 |
詳細
|
2-Amino-6-chlorophenol |
2-氨基-6-氯苯酚 |
38191-33-2 |
詳細
|
BM1-C |
3,4-二氯-5-硝基苯甲酸 |
13300-63-5 |
詳細
|
Atenolol Impurity G |
阿替洛爾雜質G |
56392-14-4 |
詳細
|
2-Chloro-4-(tert-pentyl)phenol |
2-氯-4-叔戊基苯酚 |
5323-65-9 |
詳細
|
Ilaprazole |
艾普拉唑 |
172152-36-2 |
詳細
|
Pentoxifylline Impurity J |
己酮可可堿雜質J |
874747-30-5 |
詳細
|